本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

18.42
+0.41502.31%
成交量:25.39萬
成交額:464.57萬
市值:20.44億
市盈率:-9.58
高:18.74
開:17.97
低:17.64
收:18.00
52周最高:44.34
52周最低:15.96
股本:1.11億
流通股本:1.09億
量比:0.53
換手率:0.23%
股息:- -
股息率:- -
每股收益(TTM):-1.9229
每股收益(LYR):-2.5984
淨資產收益率:-28.97%
總資產收益率:-13.29%
市淨率:2.69
市盈率(LYR):-7.09

資料載入中...

2025/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

重要事件披露

Form 8-K - Current report
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/16

重要事件披露

Form 8-K - Current report
2025/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report